PortfoliosLab logo
DXCM vs. EXAS
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between DXCM and EXAS is 0.34, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

DXCM vs. EXAS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in DexCom, Inc. (DXCM) and Exact Sciences Corporation (EXAS). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

DXCM:

-0.60

EXAS:

0.15

Sortino Ratio

DXCM:

-0.38

EXAS:

0.56

Omega Ratio

DXCM:

0.93

EXAS:

1.08

Calmar Ratio

DXCM:

-0.51

EXAS:

0.06

Martin Ratio

DXCM:

-0.82

EXAS:

0.20

Ulcer Index

DXCM:

39.25%

EXAS:

22.45%

Daily Std Dev

DXCM:

58.58%

EXAS:

58.98%

Max Drawdown

DXCM:

-94.61%

EXAS:

-98.01%

Current Drawdown

DXCM:

-47.50%

EXAS:

-63.60%

Fundamentals

Market Cap

DXCM:

$33.52B

EXAS:

$10.64B

EPS

DXCM:

$1.33

EXAS:

-$5.55

PEG Ratio

DXCM:

1.32

EXAS:

-1.07

PS Ratio

DXCM:

8.08

EXAS:

3.76

PB Ratio

DXCM:

14.82

EXAS:

4.42

Total Revenue (TTM)

DXCM:

$4.15B

EXAS:

$2.83B

Gross Profit (TTM)

DXCM:

$2.46B

EXAS:

$1.93B

EBITDA (TTM)

DXCM:

$889.80M

EXAS:

-$848.74M

Returns By Period

In the year-to-date period, DXCM achieves a 9.91% return, which is significantly higher than EXAS's 0.41% return. Over the past 10 years, DXCM has outperformed EXAS with an annualized return of 17.38%, while EXAS has yielded a comparatively lower 7.84% annualized return.


DXCM

YTD

9.91%

1M

24.66%

6M

12.65%

1Y

-34.93%

5Y*

-3.79%

10Y*

17.38%

EXAS

YTD

0.41%

1M

35.69%

6M

14.37%

1Y

11.99%

5Y*

-7.63%

10Y*

7.84%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

DXCM vs. EXAS — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DXCM
The Risk-Adjusted Performance Rank of DXCM is 2323
Overall Rank
The Sharpe Ratio Rank of DXCM is 1818
Sharpe Ratio Rank
The Sortino Ratio Rank of DXCM is 2525
Sortino Ratio Rank
The Omega Ratio Rank of DXCM is 2121
Omega Ratio Rank
The Calmar Ratio Rank of DXCM is 1818
Calmar Ratio Rank
The Martin Ratio Rank of DXCM is 3232
Martin Ratio Rank

EXAS
The Risk-Adjusted Performance Rank of EXAS is 5454
Overall Rank
The Sharpe Ratio Rank of EXAS is 5858
Sharpe Ratio Rank
The Sortino Ratio Rank of EXAS is 5353
Sortino Ratio Rank
The Omega Ratio Rank of EXAS is 5353
Omega Ratio Rank
The Calmar Ratio Rank of EXAS is 5454
Calmar Ratio Rank
The Martin Ratio Rank of EXAS is 5353
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

DXCM vs. EXAS - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for DexCom, Inc. (DXCM) and Exact Sciences Corporation (EXAS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current DXCM Sharpe Ratio is -0.60, which is lower than the EXAS Sharpe Ratio of 0.15. The chart below compares the historical Sharpe Ratios of DXCM and EXAS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

DXCM vs. EXAS - Dividend Comparison

Neither DXCM nor EXAS has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

DXCM vs. EXAS - Drawdown Comparison

The maximum DXCM drawdown since its inception was -94.61%, roughly equal to the maximum EXAS drawdown of -98.01%. Use the drawdown chart below to compare losses from any high point for DXCM and EXAS. For additional features, visit the drawdowns tool.


Loading data...

Volatility

DXCM vs. EXAS - Volatility Comparison

DexCom, Inc. (DXCM) has a higher volatility of 17.14% compared to Exact Sciences Corporation (EXAS) at 11.88%. This indicates that DXCM's price experiences larger fluctuations and is considered to be riskier than EXAS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

DXCM vs. EXAS - Financials Comparison

This section allows you to compare key financial metrics between DexCom, Inc. and Exact Sciences Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


200.00M400.00M600.00M800.00M1.00B1.20B20212022202320242025
1.04B
706.79M
(DXCM) Total Revenue
(EXAS) Total Revenue
Values in USD except per share items

DXCM vs. EXAS - Profitability Comparison

The chart below illustrates the profitability comparison between DexCom, Inc. and Exact Sciences Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

60.0%65.0%70.0%75.0%80.0%20212022202320242025
56.9%
70.8%
(DXCM) Gross Margin
(EXAS) Gross Margin
DXCM - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, DexCom, Inc. reported a gross profit of 589.00M and revenue of 1.04B. Therefore, the gross margin over that period was 56.9%.

EXAS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Exact Sciences Corporation reported a gross profit of 500.55M and revenue of 706.79M. Therefore, the gross margin over that period was 70.8%.

DXCM - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, DexCom, Inc. reported an operating income of 133.70M and revenue of 1.04B, resulting in an operating margin of 12.9%.

EXAS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Exact Sciences Corporation reported an operating income of -96.01M and revenue of 706.79M, resulting in an operating margin of -13.6%.

DXCM - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, DexCom, Inc. reported a net income of 105.40M and revenue of 1.04B, resulting in a net margin of 10.2%.

EXAS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Exact Sciences Corporation reported a net income of -101.22M and revenue of 706.79M, resulting in a net margin of -14.3%.